Paolo Trifiro′

Title: Paolo Trifiro′: Innovator in Histone Demethylase Inhibitors

Introduction

Paolo Trifiro′ is a notable inventor based in Como, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target histone demethylases. With a total of two patents to his name, Trifiro′ is recognized for his innovative approaches to therapy.

Latest Patents

Trifiro′'s latest patents include "Imidazoles as histone demethylase inhibitors." This invention relates to imidazole derivatives, which are defined in the specification, along with pharmaceutical compositions containing these compounds and their therapeutic uses. Another significant patent is "Cyclopropylamine derivatives useful as inhibitors of histone demethylases KDM1A." This invention focuses on cyclopropyl derivatives of a general formula, also defined in the specification, and includes pharmaceutical compositions and their therapeutic applications.

Career Highlights

Paolo Trifiro′ is currently associated with the Istituto Europeo Di Oncologia S.r.l., where he continues to advance his research and development efforts. His work is pivotal in the ongoing exploration of cancer therapies, particularly through the modulation of epigenetic factors.

Collaborations

Trifiro′ collaborates with esteemed colleagues such as Paola Vianello and Mario Varasi, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Paolo Trifiro′ stands out as an influential inventor in the realm of histone demethylase inhibitors, with a focus on developing novel therapeutic compounds. His contributions are vital to the advancement of cancer treatment methodologies.